US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Vifor Pharma AG
Approval of extension of exemptions from SIX disclosure and publicity obligations
October 20, 2022
From
Vifor Pharma AG
Via
Business Wire
Approval of delisting of Vifor Pharma AG's registered shares
October 12, 2022
From
Vifor Pharma AG
Via
Business Wire
Finalization of Vifor Pharma acquisition
August 02, 2022
From
Vifor Pharma AG
Via
Business Wire
Tickers
ASX:CSL
CSLLY
OTC
